Académique Documents
Professionnel Documents
Culture Documents
5/23/12
5/23/12
High morbidity 5 8 episodes/year/child 30 50 % outpatient visit 10 30 % hospitalization High mortality 30 70 times higher than in developed 5/23/12 countries
Developing countries
Distribution of 12.2 million deaths among children less than 5 years old in all developing countries, 1993
ARI/Malaria (1.6%) Malaria (6.2) ARI (26.9%)
Other (33.1%)
Malnutritio n (29%)
RISK FACTORS FOR PNEUMONIA OR DEATH FROM ARI Malnutritio n, poor breast Lack of feeding Vitamin A immunizatio practicesdeficiency Young Low birth n Increas age weight
e risk of ARI
Cold weather or Exposure to air chilling pollution Tobacco smoke 5/23/12 Biomass smoke
12.500 416 17
5/23/12
Pneumonia
Classifications
Anatomical classification
Lobular
Intertitial
Bronchopneumonia
Etiological classification
Bacterial Viral
pneumonia pneumonia
pneumonia
5/23/12
Mycoplasma
Etiology of Pneumonia
Bacterial etiology
Streptococcus pneumoniae Hemophilus influenzae Staphylococcus aureus Streptococcus group A B Klebsiella pneumoniae Pseudomonas aeruginosa Chlamydia spp Mycoplasma pneumoniae
5/23/12
BACTERIA ISOLATED FROM LUNG ASPIRATES IN 370 UNTREATED CHILDREN WITH PNEUMONIA
%
50 40 30 20 10 0
S Pneumoniae
H Influenzae
5/23/12
S Aureus
Characteristic features
S pneumoniae
mucosal alveolar
frequently
Staphylococcus, Klebsiella
destruction
5/23/12
Bronchopneumonia Early stages of acute bronchopneumonia. Abundant inflammatory cells fill the alveolar spaces. The alveolar capillaries are distended and engorged.
5/23/12
Bronchopneumonia Acute bronchopneumonia. The alveolar spaces contain abundant PMNs and an inflammatory infiltrate rich in fibrin.
5/23/12
Acute Bronchopneumonia Acute bronchopneumonia; the alveolar spaces are full and distended with PMNs and a proteinaceous exudate. Only the alveolar septa allow identification of the tissue as lung.
5/23/12
Radiographic patterns
1. Diffuse alveolar and interstitial pneumonia (perivascular and interalveolar changes)
2.Bronchopneumonia (inflammation of airways and parenchyma) 3. Lobar pneumonia (consolidation in a whole lobe) 4. Nodular, cavity or abscess lesions 5/23/12 (esp.in immunocompromised
5/23/12
5/23/12
5/23/12
with O2 3 L/min O2
52,4 %
without
100 %
Ventilatory insufficiency
(PaCO2
Ventilatory failure
(PaCO2
Metabolic Acidosis
poor
5/23/12 intake and/or hypoxemia 44,4 %
Management
Severe Pneumonia
or Gentamycin
Intra Venous Fluid Drip Oxygen Detection and management of 5/23/12 complications
Complications
5/23/12
Bronchiolitis
Bronchioles inflammation syndromes: fast breathing, retractions, wheezing < 2 years of age (2 6 months)
Clinical
Predominantly Difficult
Bronchiolitis
Etiology Predominantly RSV (Respiratory Syncytial Virus), adenovirus etc. Diagnosis Etiological diagnosis
Clinical diagnosis
Signs Age Resource
5/23/12
Bronchiolitis
Clinical Manifestations cough, cold, fever, fast breathing, retraction, wheezing, irritable, vomitus, poor intake Physical Examinations tachypnea, tachycardia, retraction, expiration >, wheezing, fever, pharyngitis, conjunctivitis, otitis media.
5/23/12
Bronchiolitis
Radiologic examination
diffuse hyperinflation
flat
subcostal
retrosternal
Bronchiolitis
Management
Supportive Severe
disease
controversial controversial
5/23/12
Bronchiolitis
5/23/12
Bronchiolitis
Similarity
5/23/12
Thank you
5/23/12